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www.sciencemag.org/cgi/content/full/339/6126/1445/DC1 Materials and Methods Figs. S1 to S12 Movies S1 to S10 References (30-33) Delphine J. Lee, 5 Evangelia Komisopoulou, 4 Kindra Kelly-Scumpia, 1 Rene Chun, 3 Shankar S. Iyer, 2 Euzenir N. Sarno, 6 Thomas H. Rea, 7 Martin Hewison, 3 John S. Adams, 3 Stephen J. Popper, 8 David A. Relman, 8, 9 Steffen Stenger, 10 Barry R. Bloom, 11 Genhong Cheng, 2 Robert L. Modlin In the selfhealing tuberculoid (T-lep) form, the host immune response is able to effectively combat the pathogen, there are few skin lesions, and bacteria are rare. In the disseminated lepromatous (L-lep) form, the host immune response fails, resulting in numerous skin lesions characterized by abundant intracellular bacilli. T-lep lesions express T H 1 cytokines including IFN-g, whereas L-lep lesions are characterized by T H 2 cytokines as well as interleukin-10 (IL-10) (4). Reversal reactions (RRs) represent a shift from the L-lep toward the T-lep form, accompanied by a reduction of bacilli in lesions and enhanced T H 1 cytokine responses (5) .
The gene expression profiles of skin lesions from leprosy lesions were first evaluated by principal component analysis and hierarchical clustering analysis (Fig. 1, A and B, and fig. S1 ), both revealing a distinct gene expression profile in L-lep lesions as compared with T-lep and RR lesions. Although the signal for all type I IFN mRNAs, including all 13 IFN-a genes and one IFN-b gene, was within the microarray background noise resulting in absent calls, integration of the leprosy gene expression profiles with IFN-induced transcriptional profiles in healthy human peripheral blood mononuclear cells (PBMCs) (6) revealed that genes specifically induced by IFN-b, including IL-10, were significantly enriched in the L-lep gene expression profile. In contrast, IFN-gspecific genes were significantly enriched in the T-lep (Fig. 1C and fig. S2 ) and RR lesions ( fig. S3) . The presence of a type I IFN gene expression signature in L-lep lesions was confirmed by analysis using the "interferome" database of IFN-regulated genes (7) (fig. S4 ).
An overall summation score of the IFN-b and IFN-g profiles of each leprosy patient, calculated by using a gene voting approach (8) www.sciencemag.org SCIENCE VOL 339 22 MARCH 2013 of infection (10) . In contrast, an IFN-g-inducible vitamin D-dependent antimicrobial pathway (11) was found in the T-lep and RR lesions ( fig. S5) .
Analogous to leprosy, most individuals infected with M. tuberculosis localize and cure or contain the infection (latent tuberculosis); but in about 10% of patients the infection progresses to clinical disease, including pulmonary tuberculosis. A key study of gene expression profiles in peripheral blood from tuberculosis patients found a differential expression of an IFN-inducible gene profile in patients with active versus latent disease ( IFN-b mRNA, detected by polymerase chain reaction (PCR), was more strongly expressed in L-lep versus T-lep lesions and L-lep versus RR lesions [analysis of variance (ANOVA), P < 0.05, Fig. 2A ]. The mRNA expression for IFNAR1, encoding one of the type I IFN receptors, was more strongly expressed in L-lep versus either T-lep or RR lesions ( Fig. 2A) . In contrast, IFN-g mRNA was more highly expressed in both T-lep and RR versus L-lep lesions (Kruskal-Wallis, P < 0.05, Fig. 2A) , consistent with previous findings by in situ hybridization (13) and PCR (4, 5) . IFN-b and IFNAR1 protein expression was also more evident in L-lep than T-lep or RR lesions, being present in cells throughout the granuloma (Fig. 2B and fig. S8 ). IFN-b protein was found to localize in macrophages in L-lep lesions (figs. S9 to S11) colocalizing with CD14, CD209, and CD163 (14) . The elevated expression of IL-10 transcripts in L-lep versus T-lep and RR in lesions, as well as other classic type I IFN-inducible genes, was also corroborated by PCR (Fig. 3A  and fig. S12 ). IL-10 protein was also more highly expressed in L-lep lesions (Fig. 3B) , in macrophages as well as T cells (figs. S13 and S14). Double immunofluorescence revealed that IFN-b and IL-10 are coexpressed in L-lep lesions, with some cells expressing individual cytokines (Fig.  3C and fig. S15 ).
Both live and sonicated M. leprae induced IFN-b mRNA and protein in vitro (Fig. 3D) . Investigation of the relation between IFN-b and IL-10 revealed that IFN-b was sufficient to induce IL-10 secretion ( fig. S16) and that M. leprae induction of IL-10 ( Fig. 3E) was partially dependent on type I IFN signaling, blocked by about 40% by monoclonal antibodies (mAbs) against IFNAR2 (anti-IFNAR2) (Fig. 3F and fig. S17 ) (9) . Together, these data provide evidence for an M. leprae→IFN-b→IL-10 pathway in L-lep lesions.
Analysis of the IFN-g-induced genes in T-lep lesions revealed several antimicrobial pathways, including activation of the vitamin D-dependent antimicrobial pathway, which leads to the induction of the antimicrobial peptides CAMP (cathelicidin) and DEFB4 (beta-defensin 2), previously shown to be involved in antimicrobial activity in leprosy (14, 15) and tuberculosis (1, 11, 16, 17) . (Fig. 4A) . The expression of both CYP27B1 and the VDR were inversely correlated with IL-10 expression in the lesions ( fig. S18) .
On the basis of the differential expression of type I versus type II IFN-inducible pathways in leprosy, we hypothesized that IFN-b and IL-10 inhibited the IFN-g-induced antimicrobial pathway. The ability of IFN-g to up-regulate CYP27B1 IFN-b or IL-10 (fig. S19) . In addition, the ability of IFN-b to inhibit IFN-g induction of CYP27B1 and VDR was reversed by the addition of neutralizing monoclonal anti-IL-10 ( fig. S19 ). IL-10 also inhibited IFN-g induction of CYP27B1 activity in macrophages (18) Fig. 4C) and was reversed by the addition of anti-IL-10 (Fig. 4C) . Thus, IFN-b was shown to inhibit the expression of key genes involved in antimicrobial activity in human monocytes and macrophages. The effect of type I and II IFNs on the viability of intracellular M. leprae was subsequently investigated in vitro by using an infection model. Because M. leprae cannot be grown in vitro, we measured viability based on the ratio of M. leprae 16S rRNA to the M. leprae repetitive element DNA (15, 21) . IFN-g induced an antimicrobial activity against M. leprae in monocytes by~35%, which was blocked~70% by pharmacologic inhibition of the VDR (Fig. 4D) and completely abrogated by the addition of either IFN-b or IL-10 ( Fig. 4F and fig. S21 ). The ability of IFN-b to inhibit the IFN-g-induced antimicrobial response against M. leprae was almost completely reversed by the addition of anti-IL-10. These studies indicate that the type I IFN program prominently expressed in L-lep lesions inhibits the IFN-g-induced antimicrobial response against M. leprae, primarily through the intermediation of IL-10 ( fig. S22) protein levels were detected. Data are represented as mean T SEM, n = 7. Statistical significance was calculated by two-tailed Student's t test. *P ≤ 0.05. (F) Human monocytes were stimulated with mLEP sonicated alone or in combination with either human IFNAR2 antibody or isotype control for 24 hours, and IL-10 protein levels were detected. Data are represented as mean T SEM, n = 4. Left graph shows the levels of IL-10 subtracted from media (average T 64.5 pg/ml), and right graph shows the percentage of inhibition of IL-10 levels. Statistical significance was calculated by one-way ANOVA, and comparison between two groups was confirmed by the posttest and Newman-Keuls multiple comparison test. ***P ≤ 0.001; ** P ≤ 0.01. IgG2a, immunoglobulin g2a.
www.sciencemag.org SCIENCE VOL 339 22 MARCH 2013 (22) or M. tuberculosis infection (23, 24) to trigger production of IL-1, a cytokine also required for induction the vitamin D antimicrobial pathway (16) . The inverse correlation between the expression of IFN-b versus IFN-g, as well as their downstream target genes, suggests that the relative expression of IFNs at the site of infection is a key determinant of the outcome of the host response in leprosy. In studying a chronic human disease, it is difficult to separate initial cause from effect, but the data indicate that the IFN-b in the fully developed disease is suppressing the development of a protective response. We also note that the relevance of the vitamin D pathway for host defense in leprosy is reflected in the genetic association of VDR single-nucleotide polymorphisms in L-lep patients (25) and the reported successful use of vitamin D as a therapeutic adjuvant in the treatment of leprosy (26) .
We believe that these findings in the spectrum of leprosy may provide useful insights into mechanisms of resistance and pathogenesis in the related mycobacterial disease, human tuberculosis. Analogous to leprosy, in tuberculosis, IFN-g is critical for control of the infection. However, in some individuals, the infection with M. tuberculosis progresses to pulmonary and disseminated disease, analogous to the progressive form of leprosy. The most striking characteristic of the blood-based profiling "signature" for active tuberculosis was the increase in a set of genes regulated by IFN-b (3, 12) , with an overlap in IFN-b-and IL-10-induced genes similar to progressive leprosy. The presence of the IL-10 signature profile in blood of tuberculosis patients and the finding of IL-10 mRNA and protein at the site of disease (27) suggest that there is likely to be a causal association between the IFN-b and IL-10 profiles in active mycobacterial diseases and tissue damage. This raises the possibility that, in individuals who are able to maintain their M. tuberculosis in a latent or persistent state, a decrease in the type II IFN response or an increase in the type I response, perhaps induced by intercurrent viral infection, could shift the balance from latent to active disease.
We suggest that tuberculosis, like leprosy, comprises a spectrum of protective and pathogenic responses (28) . From an evolutionary standpoint, if the immune response were fully effective in killing the pathogen, neither historically ancient disease would exist. When innate and acquired responses are compromised, as in HIV, tuberculosis, often seen as a chronic infectious disease, is transformed into a rapidly fatal disease, as in the case of extensively drug resistant (XDR) tuberculosis (29) . Because M. tuberculosis exists essentially only in human species, it is likely to have evolved to persist in the human population, with a sufficient number of individuals developing pathology to assure transmission by aerosol and survival of the pathogen, the remainder containing the pathogen by protective host immune responses. 
